Leading Clinical Experts Across the U.S. Unite to Support Universal Genetic Testing for all Patients with Cancer
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, joined other clinical experts in releasing a new commentary in Journal of Clinical...
Source: prnewswire.com